|
COPS7A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.321000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.256720E-03 |
| Normal-vs-Stage2 |
9.396600E-01 |
| Normal-vs-Stage3 |
7.557100E-04 |
| Normal-vs-Stage4 |
1.006670E-04 |
| Stage1-vs-Stage2 |
4.464200E-03 |
| Stage1-vs-Stage3 |
5.752600E-01 |
| Stage1-vs-Stage4 |
1.759760E-01 |
| Stage2-vs-Stage3 |
4.220100E-03 |
| Stage2-vs-Stage4 |
1.864210E-03 |
| Stage3-vs-Stage4 |
3.831000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.197000E-04 |
| Normal-vs-AfricanAmerican |
6.698500E-02 |
| Normal-vs-Asian |
5.140400E-02 |
| Caucasian-vs-AfricanAmerican |
5.211800E-01 |
| Caucasian-vs-Asian |
2.469800E-01 |
| AfricanAmerican-vs-Asian |
8.303000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.7781000000019E-05 |
| Normal-vs-Female |
6.016900E-03 |
| Male-vs-Female |
2.498000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.606100E-04 |
| Normal-vs-Age(41-60Yrs) |
9.222000E-03 |
| Normal-vs-Age(61-80Yrs) |
6.620100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.237360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.766400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.930600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.924400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.636200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.255600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.566800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.503800E-01 |
| Classical-VS-Follicular |
2.677600E-01 |
| Classical-VS-Other |
1.654430E-01 |
| Classical-VS-Normal |
6.624300E-04 |
| Tall-VS-Follicular |
1.726390E-01 |
| Tall-VS-Other |
2.870400E-01 |
| Tall-VS-Normal |
4.417400E-03 |
| Follicular-VS-Other |
2.142800E-01 |
| Follicular-VS-Normal |
1.270780E-01 |
| Other-VS-Normal |
1.286170E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.070270E-02 |
| Normal-vs-N1 |
2.36349999999108E-05 |
| N0-vs-N1 |
7.515800E-03 |
|
|
